1. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015) Authors: Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le... Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 1857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies. Issue 14 (September 2015) Authors: Picozzi, Vincent J.; Ramanathan, Ramesh K.; Lowery, Maeve A.; Ocean, Allyson J.; Mitchel, Edith P.; O'Neil, Bert H.; Guarino, Michael J.; Conkling, Paul R.; Cohen, Steven J.; Bahary, Nathan; Frank, Richard C.; Dragovich, Tomislav; Bridges, Benjamin B.; Braiteh, Fadi S.; Starodub, Alexander N.; Le... Journal: European journal of cancer Issue: Volume 51:Issue 14(2015:Sep.) Page Start: 1857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Al18F labeling of peptides and proteins1. (10th January 2014) Authors: Laverman, Peter; McBride, William J.; Sharkey, Robert M.; Goldenberg, David M.; Boerman, Otto C.; Dilworth, Jonathan R.; Pascu, Sofia I. Journal: Journal of labelled compounds & radiopharmaceuticals Issue: Volume 57:Number 4(2014) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Antibody-drug conjugates targeting TROP-2 and incorporating SN-38: A case study of anti-TROP-2 sacituzumab govitecan. Issue 6 (18th August 2019) Authors: Goldenberg, David M.; Sharkey, Robert M. Journal: MAbs Issue: Volume 11:Issue 6(2019) Page Start: 987 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BCR‐ABL1 molecular remission after 90Y‐epratuzumab tetraxetan radioimmunotherapy in CD22+ Ph+ B‐ALL: proof of principle. (12th September 2013) Authors: Chevallier, Patrice; Bodet‐Milin, Caroline; Robillard, Nelly; Eugene, Thomas; Menard, Audrey; Le, Claire; Guillaume, Thierry; Delaunay, Jacques; Escoffre‐Barbe, Martine; Wegener, William A.; Goldenberg, David M.; Kraeber‐Bodéré, Francoise Journal: European journal of haematology Issue: Volume 91:Number 6(2013:Dec.) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials. Issue 5 (12th April 2018) Authors: Gottenberg, Jacques‐Eric; Dörner, Thomas; Bootsma, Hendrika; Devauchelle‐Pensec, Valérie; Bowman, Simon J.; Mariette, Xavier; Bartz, Holger; Oortgiesen, Marga; Shock, Anthony; Koetse, Willem; Galateanu, Catrinel; Bongardt, Sabine; Wegener, William A.; Goldenberg, David M.; Meno‐Tetang, Guy; Kosut... Journal: Arthritis & rheumatology Issue: Volume 70:Issue 5(2018) Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Imaging integrin alpha‐v‐beta‐3 expression in tumors with an 18F‐labeled dimeric RGD peptide. (11th January 2013) Authors: Dijkgraaf, Ingrid; Terry, Samantha Y. A.; McBride, William J.; Goldenberg, David M.; Laverman, Peter; Franssen, Gerben M.; Oyen, Wim J. G.; Boerman, Otto C. Journal: Contrast media & molecular imaging Issue: Volume 8:Number 3(2013:May/Jun.) Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Low‐dose anti‐CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study. (6th July 2013) Authors: Liebman, Howard A.; Saleh, Mansoor N.; Bussel, James B.; Negrea, Ovidiu George; Horne, Heather; Wegener, William A.; Goldenberg, David M. Journal: British journal of haematology Issue: Volume 162:Number 5(2013:Sep.) Page Start: 693 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. New Antibody Conjugates in Cancer Therapy. (2010) Authors: Govindan, Serengulam V.; Goldenberg, David M. Other Names: Lippman Marc Academic Editor. Journal: TheScientificWorldjournal Issue: Volume 10(2010) Page Start: 2070 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimization of Dual-Labeled Antibodies for Targeted Intraoperative Imaging of Tumors. Issue 7 (1st July 2015) Authors: Rijpkema, Mark; Bos, Desirée L.; Cornelissen, Alex S.; Franssen, Gerben M.; Goldenberg, David M.; Oyen, Wim J.; Boerman, Otto C. Journal: Molecular imaging Issue: Volume 14, Issue 7(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗